Switzerland
# |
Name |
Price to Sales Ratio (P/S) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
23.01 |
Feb. 3, 2025 | USD 24.30 | -3.46% |
|
Switzerland |
|
2 |
22.23 |
Feb. 3, 2025 | USD 5.05 | -4.17% |
|
Switzerland |
|
3 |
8.59 |
Feb. 3, 2025 | USD 382.54 | -3.00% |
|
Switzerland |
|
4 |
7.73 |
Feb. 3, 2025 | USD 138.90 | -2.86% |
|
Switzerland |
|
5 |
6.83 |
Feb. 3, 2025 | USD 62.45 | -2.60% |
|
Switzerland |
|
6 |
6.49 |
Feb. 3, 2025 | USD 651.30 | 2.02% |
|
Switzerland |
|
7 |
4.47 |
Feb. 3, 2025 | USD 126.21 | -1.33% |
|
Switzerland |
|
8 |
4.02 |
Feb. 3, 2025 | USD 74.55 | -2.22% |
|
Switzerland |
|
9 |
4.00 |
Feb. 3, 2025 | USD 104.72 | -0.12% |
|
Switzerland |
|
10 |
3.52 |
Feb. 3, 2025 | USD 333.72 | 0.27% |
|
Switzerland |
|
11 |
3.23 |
Feb. 3, 2025 | USD 1.12 K | -0.26% |
|
Switzerland |
|
12 |
2.83 |
Feb. 3, 2025 | USD 43.76 | -1.99% |
|
Switzerland |
|
13 |
2.55 |
Feb. 3, 2025 | USD 27.36 | -2.78% |
|
Switzerland |
|
14 |
2.52 |
Feb. 3, 2025 | USD 250.45 | -3.26% |
|
Switzerland |
|
15 |
2.20 |
Feb. 3, 2025 | USD 161.30 | -1.97% |
|
Switzerland |
|
16 |
2.03 |
Feb. 3, 2025 | USD 46.21 | -3.47% |
|
Switzerland |
|
17 |
1.76 |
Feb. 3, 2025 | USD 17.87 | -4.83% |
|
Switzerland |
|
18 |
1.25 |
Feb. 3, 2025 | USD 60.16 | -1.72% |
|
Switzerland |
|
19 |
1.20 |
Feb. 3, 2025 | USD 15.53 | -0.65% |
|
Switzerland |
|
20 |
1.00 |
Feb. 3, 2025 | USD 88.99 | -0.28% |
|
Switzerland |
|
21 |
0.94 |
Feb. 3, 2025 | USD 13.36 | -0.81% |
|
Switzerland |
|
22 |
0.87 |
Feb. 3, 2025 | USD 1.14 K | -1.12% |
|
Switzerland |
|
23 |
0.36 |
Feb. 3, 2025 | USD 3.57 | -5.82% |
|
Switzerland |
|
24 |
0.16 |
Feb. 3, 2025 | USD 21.72 | -0.35% |
|
Switzerland |
The Healthcare company in Switzerland with the highest Price to Sales Ratio (P/S) is Kuros Biosciences AG (Swiss Stock Exchange: KURN.SW) at 23.01.
The Healthcare company in Switzerland with the lowest Price to Sales Ratio (P/S) is DocMorris AG (LSE: 0RRB.L) at 0.16.
The top 10 Healthcare companies in Switzerland by Price to Sales Ratio (P/S) are Kuros Biosciences AG, Molecular Partners AG, Ypsomed Holding AG, Straumann Holding AG, Bachem Holding AG, Lonza Group AG, Medacta Group SA, Medartis Holding AG, Novartis AG and Roche Holding AG.
The bottom 10 Healthcare companies in Switzerland by Price to Sales Ratio (P/S) are DocMorris AG, Ascom Holding AG, Metall Zug AG, medmix AG, Galenica AG, Aevis Victoria SA, COLTENE Holding AG, Santhera Pharmaceuticals Holding AG, Sandoz Group AG and IVF Hartmann Holding AG.